TY - JOUR
T1 - Intercentre variance in patient reported outcomes is lower than objective rheumatoid arthritis activity measures
T2 - a cross-sectional study
AU - Khan, Nasim Ahmed
AU - Spencer, Horace Jack
AU - Nikiphorou, Elena
AU - Naranjo, Antonio
AU - Alten, Rieki
AU - Chirieac, Rodica M
AU - Drosos, Alexandros A
AU - Géher, Pál
AU - Inanc, Nevsun
AU - Kerzberg, Eduardo
AU - Ancuta, Codrina Mihaela
AU - Müller, Rüediger
AU - Ørnbjerg, Lykke
AU - Sokka, Tuulliki
N1 - COPECARE
PY - 2017/8/1
Y1 - 2017/8/1
N2 - Objective: To assess intercentre variability in the ACR core set measures, DAS28 based on three variables (DAS28v3) and Routine Assessment of Patient Index Data 3 in a multinational study.Methods: Seven thousand and twenty-three patients were recruited (84 centres; 30 countries) using a standard protocol in the Quantitative Standard Monitoring of Patients with RA study. Analysis of variance (ANOVA) and mixed-effect analysis of covariance models were used to model the relationship between study centre and different patient-reported and physician-reported RA activity measures. These models were built to adjust for the remaining ACR core set measure (for each ACR core set measure or each composite index), socio-demographics and medical characteristics. ANOVA and analysis of covariance models yielded similar results, and ANOVA tables were used to present variance attributable to recruiting centre.Results: The proportion of variances attributable to recruiting centre was lower for patient reported outcomes (PROs: pain, HAQ, patient global) compared with objective measures (joint counts, ESR, physician global) in all models. In the full model, variance in PROs attributable to recruiting centre ranged from 1.53% for patient global to 3.71% for HAQ compared with objective measures that ranged from 5.92% for physician global to 9.25% for ESR; and was lower for Routine Assessment of Patient Index Data 3 (2.6%) compared with DAS28v3 (11.75%).Conclusion: Intercentre variability in PROs is lower than objective measures of RA activity demonstrating that PROs may be more comparable across centres, and the need for standardization of objective measures.
AB - Objective: To assess intercentre variability in the ACR core set measures, DAS28 based on three variables (DAS28v3) and Routine Assessment of Patient Index Data 3 in a multinational study.Methods: Seven thousand and twenty-three patients were recruited (84 centres; 30 countries) using a standard protocol in the Quantitative Standard Monitoring of Patients with RA study. Analysis of variance (ANOVA) and mixed-effect analysis of covariance models were used to model the relationship between study centre and different patient-reported and physician-reported RA activity measures. These models were built to adjust for the remaining ACR core set measure (for each ACR core set measure or each composite index), socio-demographics and medical characteristics. ANOVA and analysis of covariance models yielded similar results, and ANOVA tables were used to present variance attributable to recruiting centre.Results: The proportion of variances attributable to recruiting centre was lower for patient reported outcomes (PROs: pain, HAQ, patient global) compared with objective measures (joint counts, ESR, physician global) in all models. In the full model, variance in PROs attributable to recruiting centre ranged from 1.53% for patient global to 3.71% for HAQ compared with objective measures that ranged from 5.92% for physician global to 9.25% for ESR; and was lower for Routine Assessment of Patient Index Data 3 (2.6%) compared with DAS28v3 (11.75%).Conclusion: Intercentre variability in PROs is lower than objective measures of RA activity demonstrating that PROs may be more comparable across centres, and the need for standardization of objective measures.
KW - Analysis of Variance
KW - Antirheumatic Agents
KW - Arthritis, Rheumatoid
KW - Cross-Sectional Studies
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - Patient Reported Outcome Measures
KW - Reproducibility of Results
KW - Severity of Illness Index
KW - Treatment Outcome
KW - Evaluation Studies
KW - Journal Article
KW - Multicenter Study
U2 - 10.1093/rheumatology/kex076
DO - 10.1093/rheumatology/kex076
M3 - Journal article
C2 - 28575509
SN - 1462-0324
VL - 56
SP - 1395
EP - 1400
JO - Rheumatology (Oxford, England)
JF - Rheumatology (Oxford, England)
IS - 8
ER -